rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2007-8-29
|
pubmed:abstractText |
Oral contraceptive is the most commonly used method of fertility control. Yasmin is a combination of a novel progestogen with anti-androgenic and anti-mineralcorticoid activities (3 mg Drospirenone (DRSP) and 30 microg ethinylestradiol (EE)). It has been shown in many clinical trials that Yasmin is an efficacious oral contraceptive, lacking undesired effects as with other oral contraceptives such as weight gain. However the effects of Yasmin on sexual desire and libido have not been intensively investigated so far
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0125-2208
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89 Suppl 4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S17-22
|
pubmed:meshHeading |
pubmed-meshheading:17726807-Adult,
pubmed-meshheading:17726807-Androgens,
pubmed-meshheading:17726807-Androstenes,
pubmed-meshheading:17726807-Contraceptives, Oral, Synthetic,
pubmed-meshheading:17726807-Ethinyl Estradiol,
pubmed-meshheading:17726807-Female,
pubmed-meshheading:17726807-Health Surveys,
pubmed-meshheading:17726807-Humans,
pubmed-meshheading:17726807-Norpregnenes,
pubmed-meshheading:17726807-Patient Satisfaction,
pubmed-meshheading:17726807-Progesterone Congeners,
pubmed-meshheading:17726807-Questionnaires,
pubmed-meshheading:17726807-Sexual Behavior,
pubmed-meshheading:17726807-Thailand,
pubmed-meshheading:17726807-Time Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Rama IV Rd, Bangkok 10330, Thailand.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|